Literature DB >> 21597949

Treatment of bisphosphonate-induced osteonecrosis of the jaws with Nd:YAG laser biostimulation.

Marita Luomanen1, Satu Alaluusua.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21597949     DOI： 10.1007/s10103-011-0929-7

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN： 0268-8921            Impact factor:   3.161


× No keyword cloud information.
  23 in total

1.  Effect of low-power GaAlAs laser (660 nm) on bone structure and cell activity: an experimental animal study.

Authors:  Renata A Nicola; Vanda Jorgetti; Josepa Rigau; Marcos T T Pacheco; Luciene M dos Reis; Renato A Zângaro
Journal:  Lasers Med Sci       Date:  2003       Impact factor: 3.161

2.  Irradiation at 780 nm increases proliferation rate of osteoblasts independently of dexamethasone presence.

Authors:  Neusa A Fujihara; Karen R N Hiraki; Márcia M Marques
Journal:  Lasers Surg Med       Date:  2006-04       Impact factor: 4.025

3.  Early surgical approach preferable to medical therapy for bisphosphonate-related osteonecrosis of the jaws.

Authors:  Paolo Vescovi; Maddalena Manfredi; Elisabetta Merigo; Marco Meleti
Journal:  J Oral Maxillofac Surg       Date:  2008-04       Impact factor: 1.895

Review 4.  Bisphosphonates: mechanisms of action.

Authors:  G A Rodan; H A Fleisch
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

5.  Effect of low intensity laser irradiation on surgically created bony defects in rats.

Authors:  J Nissan; D Assif; M D Gross; A Yaffe; I Binderman
Journal:  J Oral Rehabil       Date:  2006-08       Impact factor: 3.837

6.  High-intensity pulsed laser irradiation accelerates bone formation in metaphyseal trabecular bone in rat femur.

Authors:  Tadashi Ninomiya; Yuuichi Miyamoto; Taku Ito; Atsushi Yamashita; Masayoshi Wakita; Tsuyoshi Nishisaka
Journal:  J Bone Miner Metab       Date:  2003       Impact factor: 2.626

7.  [New possibilities of extremity revascularization in chronic ischemia: neoangiogenesis induced by exposure to high-intensive laser (an experimental study)].

Authors:  D I Alekhin
Journal:  Angiol Sosud Khir       Date:  2003

8.  Natural history of osteonecrosis of the jaw in patients with multiple myeloma.

Authors:  Ashraf Badros; Evangelos Terpos; Eirini Katodritou; Olga Goloubeva; Efstathios Kastritis; Evgenia Verrou; Kostas Zervas; Maria R Baer; Timothy Meiller; Meletios A Dimopoulos
Journal:  J Clin Oncol       Date:  2008-11-17       Impact factor: 44.544

9.  Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases.

Authors:  Paolo Vescovi; Elisabetta Merigo; Maddalena Manfredi; Marco Meleti; Carlo Fornaini; Mauro Bonanini; Jean Paul Rocca; Samir Nammour
Journal:  Photomed Laser Surg       Date:  2008-02       Impact factor: 2.796

10.  Effect of low-intensity (3.75-25 J/cm2) near-infrared (810 nm) laser radiation on red blood cell ATPase activities and membrane structure.

Authors:  Jolanta Kujawa; Leu Zavodnik; Ilya Zavodnik; Vyacheslav Buko; Alena Lapshyna; Maria Bryszewska
Journal:  J Clin Laser Med Surg       Date:  2004-04
View more
  8 in total

1.  Photobiomodulation therapy: management of mucosal necrosis of the oropharynx in previously treated head and neck cancer patients.

Authors:  Joel B Epstein; Paul Y Song; Allen S Ho; Babak Larian; Arash Asher; Rene-Jean Bensadoun
Journal:  Support Care Cancer       Date:  2016-12-17       Impact factor: 3.603

Review 2.  Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols.

Authors:  Judith A E M Zecha; Judith E Raber-Durlacher; Raj G Nair; Joel B Epstein; Sharon Elad; Michael R Hamblin; Andrei Barasch; Cesar A Migliorati; Dan M J Milstein; Marie-Thérèse Genot; Liset Lansaat; Ron van der Brink; Josep Arnabat-Dominguez; Lisette van der Molen; Irene Jacobi; Judi van Diessen; Jan de Lange; Ludi E Smeele; Mark M Schubert; René-Jean Bensadoun
Journal:  Support Care Cancer       Date:  2016-03-17       Impact factor: 3.603

3.  Effect of Nd: YAG laser on the apical seal after root-end resection and MTA retrofill: a bacterial leakage study.

Authors:  Reza Birang; Sepideh Kiani; Ali Shokraneh; Seyed Mohsen Hasheminia
Journal:  Lasers Med Sci       Date:  2013-06-21       Impact factor: 3.161

4.  The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Protocols.

Authors:  Olga Di Fede; Federica Canepa; Vera Panzarella; Rodolfo Mauceri; Carmine Del Gaizo; Alberto Bedogni; Vittorio Fusco; Pietro Tozzo; Giuseppe Pizzo; Giuseppina Campisi; Antonio Galvano
Journal:  Int J Environ Res Public Health       Date:  2021-08-10       Impact factor: 3.390

Review 5.  Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): a systematic review.

Authors:  João Batista Blessmann Weber; Renata Stifelman Camilotti; Monique Estér Ponte
Journal:  Lasers Med Sci       Date:  2016-03-30       Impact factor: 3.161

6.  Conservative treatment of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients.

Authors:  Pelagia I Melea; Ioannis Melakopoulos; Efstathios Kastritis; Christina Tesseromatis; Vasileios Margaritis; Meletios A Dimopoulos; Evangelos Terpos
Journal:  Int J Dent       Date:  2014-06-17

7.  Effect of Photobiomodulation on Transforming Growth Factor-β1, Platelet-Derived Growth Factor-BB, and Interleukin-8 Release in Palatal Wounds After Free Gingival Graft Harvesting: A Randomized Clinical Study.

Authors:  Ilker Keskiner; Muge Lutfioğlu; Ahmet Aydogdu; N Isil Saygun; Muhittin A Serdar
Journal:  Photomed Laser Surg       Date:  2016-04-18       Impact factor: 2.796

8.  Complementarity of surgical therapy, photobiomodulation, A-PRF and L-PRF for management of medication-related osteonecrosis of the jaw (MRONJ): an animal study.

Authors:  Mohammad Reza Jamalpour; Shiva Shahabi; Mehdi Baghestani; Abbas Shokri; Shokoofeh Jamshidi; Salman Khazaei
Journal:  BMC Oral Health       Date:  2022-06-18       Impact factor: 3.747
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.